R1 RCM Inc. (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners, L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company. The underwriters will have a 30-day option to purchase up to an additional 2,250,000 shares of common stock from TCP-ASC. R1 RCM is not selling any shares in the offering and will not receive any of the proceeds from the sale of common stock by the selling stockholders.

Barclays, J.P. Morgan, Morgan Stanley, BofA Securities and Deutsche Bank Securities are serving as active bookrunners for this offering.